​

Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 62.34% institutional investors, 18.09% insiders, and 19.58% retail investors. Mak capital one is the largest institutional shareholder, holding 9.78% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockAutolus Therapeutics62.34%18.09%19.58%
SectorHealthcare Stocks 492.67%11.09%-403.76%
IndustryBiotech Stocks 295.31%11.22%-206.53%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Mak capital one26.02M9.78%$42.41M
Blackstone20.49M7.70%$33.39M
Syncona portfolio16.64M6.25%$27.12M
Armistice capital15.60M5.86%$25.43M
Tfg asset management gp9.50M3.57%$15.48M
Schroder investment management group8.43M3.17%$13.41B
Blackrock4.44M2.00%$15.44M
Renaissance4.88M1.83%$7.96M
Frazier life sciences management4.62M1.74%$7.54M
Blackrock funding, inc. /de3.47M1.31%$5.66M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio16.64M97.82%$27.12M
Mak capital one26.02M6.52%$42.41M
Tfg asset management gp9.50M2.07%$15.48M
Healthinvest partners ab1.17M0.75%$202.40K
Armistice capital15.60M0.38%$25.43M
Affinity asset advisors1.75M0.25%$2.85M
Frazier life sciences management4.62M0.23%$7.54M
Diametric capital, lp257.23K0.16%$419.29K
Blackstone20.49M0.13%$33.39M
Aubrey capital management234.45K0.12%$374.83K

Top Buyers

HolderShares% AssetsChange
Mak capital one26.02M6.52%9.06M
Schroder investment management group8.43M0.01%4.82M
Armistice capital15.60M0.38%3.60M
Axa investment managers3.36M0.01%3.36M
Renaissance4.88M0.01%3.13M

Top Sellers

HolderShares% AssetsChange
Wellington management group llp---27.15M
Deep track capital, lp2.57M0.12%-14.28M
Avoro capital advisors---9.91M
Fmr---7.11M
Cormorant asset management, lp---6.62M

New Positions

HolderShares% AssetsChangeValue
Axa investment managers3.36M0.01%3.36M$5.48M
Acadian asset management1.85M0.01%1.85M$3.01M
Hrt financial lp210.17K0.00%210.17K$342.00K
Graham capital management147.88K0.00%147.88K$241.04K
Public employees retirement system of ohio132.69K0.00%132.69K$216.28K

Sold Out

HolderChange
Us bancorp \de\-64.00
Cornerstone planning group-100.00
Raymond james financial-200.00
Carmichael hill & associates-254.00
Skopos labs-377.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202593-2.11%165,894,0399.60%621.93%4925.64%27-15.63%
Mar 31, 202595-12.04%168,007,060-0.18%631.58%39-29.09%326.67%
Dec 31, 20241053.96%163,675,281-8.36%611.37%5450.00%30-16.67%
Sep 30, 202499-10.00%178,343,7070.33%671.05%36-33.33%3520.69%
Jun 30, 2024110-9.09%177,754,5781.37%801.28%54-23.94%297.41%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Syncona Ord30.73M11.55%9.39M
Vanguard Health Care Inv19.36M7.27%-
FIAM Small Cap Core CIT Cl B4.02M1.51%946.70K
FIAM Small Cap Core Composite3.14M1.18%-26.57K
Fidelity Small Cap Growth2.57M0.97%-
International Biotechnology Ord2.41M0.90%472.01K
AXA Framlington Health Fund - R Income2.37M0.89%-751.84K
US Small-Cap Growth II Equity Comp2.02M0.76%-216.32K
Wellington Global Hlthcr Eq USD G Ac1.79M0.67%-
Fidelity Stock Selector Small Cap1.62M0.61%-348.11K

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 62.34%, followed by 18.09% insiders and 19.57% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 295.31%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Mak capital one (26.02M shares, 9.78%), Blackstone (20.49M shares, 7.70%), and Syncona portfolio (16.64M shares, 6.25%). Together, they hold 23.73% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 97.82% of its assets in 16.64M Autolus Therapeutics shares, valued at 27.12M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools